Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1
Abstract E74-like ETS transcription factor 5 (ELF5) is involved in a wide spectrum of biological processes, e.g., mammogenesis and tumor progression. We have identified a list of p300-interacting proteins in human breast cancer cells. Among these, ELF5 was found to interact with p300 via acetylation...
Saved in:
Main Authors: | Xiahui Li, Shujing Li, Bowen Li, Yanan Li, Sattout Aman, Kangkai Xia, Yuxi Yang, Bashir Ahmad, Huijian Wu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/763b9e5df05043e0a6a0ddf5e84af082 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9
by: Sattout Aman, et al.
Published: (2021) -
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
by: Maria Kalyuga, et al.
Published: (2012) -
Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression
by: Yang Chen, et al.
Published: (2017) -
Cell Cycle Regulation by Alternative Polyadenylation of CCND1
by: Qiong Wang, et al.
Published: (2018) -
Acetylation-mediated suppression of transcription-independent memory: bidirectional modulation of memory by acetylation.
by: Katja Merschbaecher, et al.
Published: (2012)